Surveillance of Adverse Drug Reactions to First-line Antituberculosis Drugs Using Common Data Model
Journal of Pharmacoepidemiology and Risk Management · 2021
DOI: 10.56142/2021.13.2.78 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, 2021. Verfasst von Sun-ju Byeon und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Sun-ju Byeon, MD, PhD, Hang A Park, MD, PhD, Dong Yoon Kang, MD, PhD, In Young Choi, PhD and Jeong-Hee Choi, MD, PhD. Journal of Pharmacoepidemiology and Risk Management 2021;13:78-86. https://doi.org/10.56142/2021.13.2.78
Zitieren
APA
Byeon, S., Park, H. A., Kang, D. Y., Choi, I. Y., & Choi, J. (2021). Surveillance of Adverse Drug Reactions to First-line Antituberculosis Drugs Using Common Data Model. Journal of Pharmacoepidemiology and Risk Management. https://doi.org/10.56142/2021.13.2.78
Vancouver
Byeon S, Park HA, Kang DY, Choi IY, Choi J. Surveillance of Adverse Drug Reactions to First-line Antituberculosis Drugs Using Common Data Model. Journal of Pharmacoepidemiology and Risk Management. 2021. doi:10.56142/2021.13.2.78
BibTeX
@article{Byeon2021,
author = {Byeon, Sun-ju and Park, Hang A and Kang, Dong Yoon and Choi, In Young and Choi, Jeong-Hee},
title = {Surveillance of Adverse Drug Reactions to First-line Antituberculosis Drugs Using Common Data Model},
journal = {Journal of Pharmacoepidemiology and Risk Management},
year = {2021},
doi = {10.56142/2021.13.2.78}
}
EUVIMED